318
Participants
Start Date
December 11, 2007
Primary Completion Date
June 26, 2009
Study Completion Date
June 26, 2009
PF-04217329 - Lowest Dose
1 drop of lowest dose PF-04217329, once a day, per dosed eye for duration of study.
PF-04217329 - Low Dose
1 drop of low dose PF-04217329, once a day, per dosed eye for duration of study.
PF-04217329 - Middle Dose
1 drop of middle dose PF-04217329, once a day, per dosed eye for duration of study.
PF-04217329 - High Middle Dose
1 drop of high middle dose PF-04217329, once a day, per dosed eye for duration of study.
PF-04217329 - High Dose
1 drop of high dose PF-04217329, once a day, per dosed eye for duration of study.
PF-4217329 - Highest Dose
1 drop of highest dose PF-04217329, once a day, per dosed eye for duration of study.
PF-04217329 - Vehicle
1 drop of PF-04217329 vehicle, once a day, per dosed eye for duration of study.
Latanoprost Vehicle
1 drop of latanoprost vehicle, once a day, per dosed eye for duration of study.
PF-04217329 - Low Dose
Five minutes after latanoprost vehicle, 1 drop of low dose PF-04217329, once a day, per dosed eye for duration of study.
Latanoprost Vehicle
1 drop of latanoprost vehicle, once a day, per dosed eye for duration of study.
PF-04217329 - Middle Dose
Five minutes after latanoprost vehicle, 1 drop of middle dose PF-04217329, once a day, per dosed eye for duration of study.
Latanoprost Vehicle
1 drop of latanoprost vehicle, once a day, per dosed eye for duration of study.
PF-04217329 - High Dose
Five minutes after latanoprost vehicle, 1 drop of high dose PF-04217329, once a day, per dosed eye for duration of study.
Latanoprost 0.005%
1 drop of latanoprost 0.005%, once a day, per dosed eye for duration of study.
PF-04217329 - Low Dose
Five minutes after latanoprost 0.005%, 1 drop of low dose PF-04217329, once a day, per dosed eye for duration of study.
Latanoprost 0.005%
1 drop of latanoprost 0.005%, once a day, per dosed eye for duration of study.
PF-04217329 - Middle Dose
Five minutes after latanoprost 0.005%, 1 drop middle dose PF-04217329, once a day, per dosed eye for duration of study.
Latanoprost 0.005%
1 drop of latanoprost 0.005%, once a day, per dosed eye for duration of study.
PF-04217329 - High Dose
Five minutes after latanoprost 0.005%, 1 drop high dose PF-04217329, once a day, per dosed eye for duration of study.
Latanoprost 0.005%
1 drop of latanoprost 0.005%, once a day, per dosed eye for duration of study.
PF-04217329 - Vehicle
Five minutes after latanoprost 0.005%, 1 drop of PF-04217329 vehicle, once a day, per dosed eye for duration of study.
Rochester Ophthalmological Group, PC, Rochester
Glaucoma Care Center at Century Eye Care, Bristol
Wills Eye Institute, Philadelphia
Cornerstone Eye Care, High Point
Charlotte Eye Ear Nose and Throat Associates, PA, Charlotte
Eye Care Centers Management, Inc., Morrow
Coastal Research Associates,LLC, Atlanta
Omni Eye Services of Atlanta, Atlanta
Atlantic Institute of Clinical Research, Daytona Beach
Florida Health Care Plans, Daytona Beach
International Eye Associates, PA, Ormond Beach
Eye Associates of Fort Myers, Fort Myers
Total Eye Care, PA, Memphis
Taustine Eye Center, Louisville
The Eye Group of Southern Indiana, Evansville
Mark J. Weiss, MD. Inc., Tulsa
Texan Eye Care, PA, Austin
Eye Physicians of Austin, Austin
Sall Research Medical Center, Artesia
Centre For Health Care, Poway
Eye Research Foundation, Newport Beach
North Bay Eye Associates, Inc., Petaluma
Bluestein Custom Vision, Charleston
Lead Sponsor
Pfizer
INDUSTRY